UIM6:XETRA:XETRA-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 458.74

Change

0.00 (0.00)%

Market Cap

USD 0.47B

Volume

160.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.46 (+0.92%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.14 (+0.88%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.25 (+0.96%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.22 (+0.79%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.24 (+1.02%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.64 (-0.42%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.19 (+0.44%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.03%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.45 (+0.89%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.84 (+0.75%)

USD 80.38B

ETFs Containing UIM6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.50% 80% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.50% 80% B- 78% C+
Trailing 12 Months  
Capital Gain 27.20% 85% B 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.20% 85% B 84% B
Trailing 5 Years  
Capital Gain 82.18% 93% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.18% 93% A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 13.00% 86% B+ 83% B
Dividend Return 13.17% 86% B+ 82% B
Total Return 0.17% 39% F 58% F
Risk Return Profile  
Volatility (Standard Deviation) 14.64% 41% F 52% F
Risk Adjusted Return 89.97% 97% N/A 96% N/A
Market Capitalization 0.47B 66% D+ 59% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.